Local view for "http://purl.org/linkedpolitics/eu/plenary/2002-09-24-Speech-2-240"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2002-09-24"^^xsd:date2
dcterms:Is Part Of	lp_eu:General debate on the general budget of the European Union for the financial year 20032
dcterms:Language	"nl"^^xsd:language2
lpv:document identification number	"en.20020924.10.2-240"2
lpv:hasSubsequent	lp_eu:2002-09-24-Speech-2-2412
lpv:speaker	lp:Jan Mulder2
lpv:spokenAs	member; Delegation to the EU-Poland Joint Parliamentary Committee (2002-02-06--2004-04-30)3 member; ELDR (1999-07-20--2004-07-19)3 substitute; CONT (2002-01-17--2004-07-19)3 substitute; AGRI (2002-01-17--2004-07-19)3 member; BUDG (2002-01-17--2004-07-19)3 unknown; Volkspartij voor Vrijheid en Democratie (1999-07-20--2004-07-19)3 substitute; Delegation to the EU-Hungary Joint Parliamentary Committee (2002-02-06--2004-04-30)3 vice-chair; Temporary committee on foot and mouth disease (2002-02-21--2002-12-17)3
lpv:translated text	"Mr President, in my opinion, Commissioner Fischler has a vision for the future, since he has already answered a number of questions on the mid-term review and about the supplementary and amending budget of October. However, I have a question on the period that follows. In the Böge report on enlargement, which we adopted in May of this year, Parliament asked the Commission to outline agricultural policy after 2006 and what the expenses would roughly be. The mid-term review does not include the milk quotas reform, but options are given instead. What are the costs of those options? Are there, within the framework of changing the sugar policy, plans in connection with Everything but Arms, and what are the costs involved? My next point concerns next year's budget and also, to some extent, this year's. Parliament had tabled a number of amendments to examine how we could protect ourselves against the outbreak of infectious animal diseases, such as foot and mouth disease, and how more funding can be made available for the development of marker vaccines and ancillary testing methods. As far as I know, it is nearly October and the Commission has shown no intention of launching these initiatives. Some preparatory work has been done, but neither of the studies has been started. It is, in my view, extremely serious that approximately nine months following the adoption of the budget, not even a start has been made on two issues that are so important for public opinion."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph